Individual Assignment Engaging in CIO-CxO "Conversations that Matter": An Interview with Peter Keen. MIS Quarterly Executive 9(1): (2010). Hamza Lahkim Bennani 10-24-2012 MIS 3301 Dr. Chihab Benmoussa Reflection Q1: I have heard you say more than once that CxOs are not interested in “IT.” Can you explain what you mean by that? Peter Keen‚ The chairman and advisor of Keen Innovations‚ answered this question very clearly‚ where he stated that it is important that CxOs
Premium Business Strategic management Chief information officer
Volume XI‚ Number 2‚ February 2011 MãçÙ®ãù S㮽½ MããÙÝ: W«ù D®¦®ã®þ P½ã¥ÊÙà ®Ý EÝÝÄ㮽 ãÊ BçÝ®ÄÝÝ SçÝÝ Jeanne W. Ross‚ Director & Principal Research ScienƟst MIT Center for InformaƟon Systems Research Cynthia M. Beath‚ Professor Emeritus University of Texas‚ AusƟn In today’s digital economy‚ business success increasingly depends on ITenabled capabilities‚ like process optimization and business intelligence. MIT CISR research has found that excelling at these IT-enabled capabilities
Premium Business process Business process management Data management
1. Introduction ........................................................................................................2 2. The stance of Pfizer ............................................................................................3 2.1 Theories of corporate social responsibility and ethics ...................................3 2.2 Pfizer ’s stance on CSR and ethics ..................................................................4 Bribery of Big Pharma ’s ....................
Premium Business ethics Corporate social responsibility Social responsibility
the way to gain the top spot as the market share leader. Warner-Lambert developed the drug initially but needed to catch up in the market so they teamed up with Pfizer‚ known for their marketing and sales competency. This partnership was just what the doctor ordered for the initial introduction of Lipitor to the market. In 2001‚ Pfizer took full control of Lipitor and changed the marketing game once again. The strategic marketing efforts created competitive advantage for the drug by “delivering
Premium Clinical trial Marketing Pharmaceutical industry
Strategy "We aim to gain leadership positions in key growing therapeutic areas and focus on delivering patient-centric‚ innovative therapies. We seek strong‚ long-term relationships that fit our goals and offer a shared vision “ * Company Background: Pfizer is a research-based global pharmaceutical company. The company discovers‚ develops‚ manufactures and markets medicines for humans and animals‚ as well as consumer products. In order To maximize new opportunities in biomedical research‚ and bring more
Premium Pharmaceutical industry Generic drug
Introduction II. About Lipitor (Atorvastatin) III. Pfizer’s strategy IV. Patients seem to benefit from Pfizer’s new strategy V. Potentially profitable for retailers VI. Pfizer after Lipitor VII. Is Pfizer’s Lipitor strategy working? VIII. Wholesaler Profits: Brand vs. Generic drug IX. Pfizer is hoping to sell Lipitor to consumers over the counter (OTC) X. Discussion XI. References Introduction Lipitor (Atorvastatin)‚ the best-selling
Premium Generic drug Food and Drug Administration Pharmaceutical industry
known as acid-test ratio‚ calculates a company’s cash and accounts receivable divided by its current liabilities. This ratio is a more stringent measure of liquidity than the current ratio in that it excludes inventories and other current assets. Pfizer has a quick ratio of 1.78 while the industry median is 1.21. This shows the company does not rely too much on inventory of other assets to pay for short-term liabilities. The current ratio measures a company’s current assets divided by its current
Premium Asset Balance sheet Generally Accepted Accounting Principles
Neurontin was ineffective and went forward. IV. Through my speech you will learn about Pfizer‚ who committed drug fraud and had to pay hefty fines. A. First‚ I will explain who Pfizer is and what the drug Neurontin does. B. Second‚ I will explain what they have done. C. Finally‚ I will discuss the outcome for Pfizer. Body I. I will explain who Pfizer is and what the drug Neurontin does. A. Pfizer is a pharmaceutical company that is dedicated to discovering and developing new and
Premium Epilepsy
Phyllis Hebert and Sierra Harkness FIN571 February 23‚ 2015 William Stokes Cost of Capital In the Wiley plus simulation (2012)‚ we are introduced to Pfizer‚ the world ’s largest research-based pharmaceutical company‚ Pfizer develops their own pharmaceutical products. Ahmed Singh‚ a consultant accountant who works for the Pfizer Treasury Department‚ explains that his role in the company is "to think and plan ahead for what should be the optimal plan structure for the company" (Wiley Plus
Premium Finance Investment Pharmacology
QUESTION 1 It is only companies that put extra effort and resources into developing‚ training and properly incentivising their workforce that will be able to retain their good staff. Critically discuss how Pfizer‚ with their biggest challenge being “the skills shortage and the retention of talented and skilled staff”‚ attempts to overcome this challenge. 1.1 Introduction The twenty-first century is characterized by businesses that are evolving in a rapidly changing and competitive environment
Premium Human resource management Management